15.11.24
Dawn's reflection: hope from Tigem research
The child, born with mucopolysaccharidosis type 6, was treated with gene therapy in 2020 and to date her liver is able to produce the missing enzyme that causes the disease.
11.10.24
A hope twelve thousand kilometres long
The story of Amari, who came from the small Caribbean Island of Trinidad to Milan to receive gene therapy for his rare genetic disorder of the immune system.
02.08.24
Violet's story: between research and outreach
The Canadian girl was born with mucopolysaccharidosis type 6. With help from the Isaac Foundation, she received important therapies in her country and participated in Italy in the trial developed by the Telethon Institute of Genetics and Medicine.
04.11.26
Lowe syndrome: from basic research to the first clinical trial
After more than twenty years of research into the cellular mechanisms underlying Lowe syndrome, a compound is moving into clinical testing for this rare genetic disease.
03.11.26
Ten years of “Just like Home”: supporting families throughout the treatment journey
Launched in 2016, “Just like Home” has so far supported 140 patients through a long and complex journey that, for many, begins thousands of kilometers from home.
22.10.26
Tigem contributes to Carbon-X, the Open-Source AI Model helping decode the human genome
The Telethon Institute of Genetics and Medicine (TIGEM) has contributed to the development of a new open-source artificial intelligence model designed to make advanced genomic analysis and DNA interpretation tools more accessible to researchers worldwide.
